Skip to main content
Elsevier
View Cart
Your Account

Books in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

BooksJournals

Advances in Immunology

  • 1st Edition
  • Volume 160
  • November 24, 2023
  • Frederick W. Alt + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 2 2 2 3 6 - 8
  • eBook
    9 7 8 - 0 - 4 4 3 - 2 2 2 3 7 - 5
Advances in Immunology, Volume 160, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

Advances in Immunology

  • 1st Edition
  • Volume 159
  • November 21, 2023
  • Frederick W. Alt + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 9 3 3 2 - 3
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 9 3 3 3 - 0
Advances in Immunology, Volume 159, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology with chapters covering topics such as the cGAS-STING pathway.

Advances in Cancer Research

  • 1st Edition
  • Volume 160
  • August 31, 2023
  • Paul B. Fisher + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 9 2 8 0 - 7
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 9 2 8 1 - 4
Advances in Cancer Research, Volume 160, the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research, with this updated edition covering PFKP: More Than Phosphofructokinase, Setting sail: maneuvering SHP2 activity and its effects in cancer, Mechanical factors driving cancer progression, Microsomal Glutathione Transferase 1 in Cancer and the Regulation of Ferroptosis, Lnc-ing epigenetic mechanisms with autophagy and cancer drug resistance, Head and Neck Cancer Treatment in the Era of Molecular Medicine, Applications of Tissue-Specific and Cancer-Selective Gene Promoters for Cancer Diagnosis and Therapy, and more.

Advances in Immunology

  • 1st Edition
  • Volume 158
  • July 13, 2023
  • Frederick W. Alt + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 9 3 3 0 - 9
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 9 3 3 1 - 6
Advances in Immunology, Volume 158, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.

Translational Neuroimmunology, Volume 7

  • 1st Edition
  • June 16, 2023
  • Nima Rezaei + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 3 2 3 - 8 5 8 4 1 - 0
  • eBook
    9 7 8 - 0 - 3 2 3 - 9 0 0 7 1 - 3
Translational NeuroImmunology: Neuroinflammation updates on bench to bedside studies on neurological disorders that have immunological etiologies. The book covers neuroimmunology and the principles of autoimmune and autoinflammatory neurological disorders, with multiple sclerosis as the main focus. The immunopathology, genetics and epigenetics, microbiome, diagnosis and treatment of multiple sclerosis will be explained in ten chapters. A chapter also examines distinct aspects of pericytes, with final discussions on the neurologic manifestations, diagnostic approaches and treatments of the various neuroimmune disorders and lessons learned from translational research on non-human primates and zebrafish. All sections are presented in an accessible, practical format, making this volume a valuable resource for immunologists, neurologists and researchers in translational biomedical research.

Translational Neuroimmunology, Volume 8

  • 1st Edition
  • June 16, 2023
  • Nima Rezaei + 1 more
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 1 8 5 7 8 - 6
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 8 5 7 9 - 3
Translational Neuroimmunology: Multiple Sclerosis provides an update on bench to bedside studies on Multiple Sclerosis as an autoimmune disease. Divided into twelve chapters, the book begins with an in-depth introduction to the neuroimmunology and immunopathology of multiple sclerosis. Sections also provide content on genetics and epigenetics, the microbiome, diagnosis, and treatment of multiple sclerosis. Finally, various precision treatments are covered. All information is presented in an accessible, practical format, making this volume a valuable resource for immunologists, neurologists and researchers in translational biomedical research.

Pancreatic Cancer: Basic Mechanisms and Therapies

  • 1st Edition
  • Volume 159
  • May 31, 2023
  • Luni Emdad + 4 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 3 3 5 4 - 1
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 3 5 5 - 8
Pancreatic Cancer: Basic Mechanisms and Therapies, Volume 159 in the Advances in Cancer Research, presents the latest release in this ongoing, well-regarded serial with invaluable information on the exciting and fast-moving field of cancer research. Pancreatic cancer (PC) is the third leading cause of cancer-related deaths in the United States. Greater than 90% PCs are Pancreatic ductal adenocarcinomas (PDAC) which have a dismal estimated 5-year overall survival of only 11%. PDAC is predicted to become the second leading cause of mortality in the United States by 2030. In the clinic, the PDAC patients often present with incurable disease at the time of first diagnosis. This cancer is particularly lethal because of its propensity to spread quickly to distant organs including the lymphatic system. PDAC metastasis occurs shortly after tumor initiation and is caused by a complex interaction between autonomous tumor cells and cellular elements of the tumor microenvironment. Although PDAC remains a challenging disease to treat and a leading cause of cancer-related deaths, progress is being made in disease etiology and pathogenesis, and intensive research is focused on developing optimal treatment approaches for patients. Considering the continuous progress being made in understanding PDAC pathogenesis and designing new therapies, it was considered timely to develop an up-to-date thematic issue of Advances in Cancer Research (ACR) focused on PDAC. In this thematic issue, we have included ten review articles by experts that cover cancer disparities, PDAC pathobiology, the roles of the tumor microenvironment, tumor heterogeneity, PC stem cells, genetic and signaling events critical for PDAC pathogenesis, Immunotherapy and chemoresistance in PDAC, and different PDAC mouse models. This special issue highlights recent research progress in PDAC, which bridges the gap between basic and clinical research.

Advances in Immunology

  • 1st Edition
  • Volume 157
  • April 11, 2023
  • Frederick W. Alt + 1 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 9 3 2 8 - 6
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 9 3 2 9 - 3
Advances in Immunology, Volume 157, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Chapters in this new release include Antigen receptor structure and signaling, T cells in the brain inflammation, The molecular mechanism of RIG-I/MDA5 activation and signaling, GSDMD biology, cGAS-STING pathway, The CARD8 inflammasome in HIV infection, and much more.

Epigenetic Regulation of Cancer in Response to Chemotherapy

  • 1st Edition
  • Volume 158
  • March 27, 2023
  • Joseph Landry + 2 more
  • English
  • Hardback
    9 7 8 - 0 - 4 4 3 - 1 9 4 1 8 - 4
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 9 4 1 9 - 1
Epigenetic Regulation of Cancer in Response to Chemotherapy, Volume 158 of the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting chapters on timely topics, including Epigenetically Programmed Resistance to Chemotherapy and Promotion of Immune Evasion in Cancer, A Role for the Epigenome in Cancer Cell Drug Tolerance, Histone Methylation and X Chromosomal Genes in Metastasis of Breast Cancer, Targeting Epigenetic Regulation Using Small Molecule Inhibitors, Histone Deacetylase Inhibitors as Sanguine Epigenetic Therapeutics against Pugnacious Lung Cancer, From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (Artemia), and more. Additional chapters cover Predictive Models of Chemoresistance Generated by Crunching the Public Drug Screen, Epigenomic and Genomic Profiling Datasets via Regression-, Machine Learning, and Knowledge-Based Methods, Probing on the Mechanisms of lncRNAs on Cancer Drug Resistance, Drug Tolerant Persister Cells in Cancer: Current Knowledge and Therapeutic Perspectives, and much more.

In Silico Approach Towards Magnetic Fluid Hyperthermia of Cancer Treatment

  • 1st Edition
  • February 28, 2023
  • Muhammad Suleman
  • English
  • Paperback
    9 7 8 - 0 - 4 4 3 - 1 3 2 8 6 - 5
  • eBook
    9 7 8 - 0 - 4 4 3 - 1 3 2 8 7 - 2
In Silico Approach Towards Magnetic Fluid Hyperthermia in Cancer Treatment: Modeling and Simulation presents mathematical modeling and simulation approaches contrary to costly and time consuming in-vivo and in-vitro studies. Finite element method-based models of all hyperthermia processes of liver, brain and breast tumors are simulated on COMSOL Multiphysics software. Problems of constant versus variable heat sources, the backflow problem, the enhanced permeation and retention effect, the flow around Happel’s sphere in cells model structure, the deformation effect in poroelastic brain tumor, 3D flow through porous tissue, the reacting nanofluid flows, and optimization of parameters have been simulated for quantitative analysis. This important reference aids in hyperthermia treatment planning in clinical applications and provides an important compendium for practitioners as well as non-medical practicing scientists and engineers and is resource for both research and medical practice in hyperthermia treatment planning in clinical applications.

Related subjects

Applied immunology

Basic immunology

Immunological methods

Immunopathogenesis